about
Analysis of cross-reactive neutralizing antibodies in human HFMD serum with an EV71 pseudovirus-based assay.Construction and characterization of an infectious cDNA clone of Echovirus 25.Rationally designed chemokine-based toxin targeting the viral G protein-coupled receptor US28 potently inhibits cytomegalovirus infection in vivo.A Broadly Cross-protective Vaccine Presenting the Neighboring Epitopes within the VP1 GH Loop and VP2 EF Loop of Enterovirus 71.Detection and analysis of tupaia hepatocytes via mAbs against tupaia serum albumin.Insights into the function of tegument proteins from the varicella zoster virus.ORF7 of Varicella-Zoster Virus Is Required for Viral Cytoplasmic Envelopment in Differentiated Neuronal Cells.Functional analysis of human cytomegalovirus UL/b' region using SCID-hu mouse model.Construction and characterization of an infectious clone of coxsackievirus A6 that showed high virulence in neonatal mice.A monoclonal antibody-based VZV glycoprotein E quantitative assay and its application on antigen quantitation in VZV vaccine.Development of a varicella-zoster virus neutralization assay using a glycoprotein K antibody enzyme-linked immunosorbent spot assay.Varicella-zoster virus ORF7 interacts with ORF53 and plays a role in its trans-Golgi network localization.Zika Virus Fatally Infects Wild Type Neonatal Mice and Replicates in Central Nervous System.Discovery and structural characterization of a therapeutic antibody against coxsackievirus A10A potential therapeutic neutralization monoclonal antibody specifically against multi-coxsackievirus A16 strains challengeRobust in vitro assay for analyzing the neutralization activity of serum specimens against hepatitis B virusA unique B cell epitope-based particulate vaccine shows effective suppression of hepatitis B surface antigen in miceAnimal models for emerging coronavirus: progress and new insights
P50
Q33806668-E64FEA4F-8A98-4D8C-9DBB-2D0C78769352Q35640256-142E92CD-A661-4F96-9AD5-A2AE89DFC334Q35845907-0B03D5AB-8275-42F1-8A52-CE80EE819401Q35917729-BA96BF17-29AC-4ACF-BA2C-35F0DAEBF3EBQ36918300-033FDC31-4C2A-4241-B64B-EAFEA80F776FQ38553727-E5C62C80-148A-4563-9C71-F37B42558158Q38709702-1E8F0507-B50C-446D-9CF6-248081CE66E9Q38767171-1E2B9D25-D3E7-4FA8-B5C7-658F36566D0CQ38974389-34DF5577-F831-4DA1-93C2-04699CA78925Q41264182-72CBDC45-D912-493D-8AC4-6F17109293A1Q42230113-7F6BB98C-A4FC-4CF3-88C1-4A15C568867EQ45325126-E598C4F5-CFAD-4E21-B990-2D79724E641FQ47549681-7824CEFC-B0D1-4FC7-BA74-F1C017AD47B2Q58717985-09F07008-7EA5-48BF-AEF5-40F4382F1E71Q91420260-220F7D80-9B06-4C4D-9E68-DBCD351DFCDDQ92301863-0195235E-92E5-472B-9531-88D8B92AFB13Q92707338-DC91C216-A4C9-4E49-AC1C-BFA1558FC21CQ94601831-EE004612-EAB1-4804-AF0E-9414040AB158
P50
description
researcher (ORCID 0000-0002-1638-6214)
@en
wetenschapper
@nl
name
Tong Cheng
@en
Tong Cheng
@nl
type
label
Tong Cheng
@en
Tong Cheng
@nl
prefLabel
Tong Cheng
@en
Tong Cheng
@nl
P31
P496
0000-0002-1638-6214